	Dec'05	Dec'06	Dec'07	Jan'09	Jan'10	Dec'10	Dec'11	Dec'12	Jan'14	Jan'15	Jan'16	Dec'16	Dec'17	Dec'18	Jan'20	Jan'21	Dec'21	Dec'22	Dec'23	Jan'25
Revenue % growth	155.2 2.4%	168.5 8.6%	205.1 21.8%	228.8 11.5%	227.9 (0.4%)	248.8 9.2%	272.4 9.5%	292.7 7.4%	296.2 1.2%	304.7 2.9%	312.8 2.7%	315.1 0.7%	347.8 10.4%	379.5 9.1%	417.2 9.9%	399.9 (4.1%)	466.3 16.6%	513.3 10.1%	536.8 4.6%	558.5 4.1%
Cost of Goods Sold (COGS)	31.0	31.6	43.7	156.1	162.3	171.7	182.6	26.1	16.1	15.5	17.1	15.9	18.1	24.9	25.8	303.8	32.6	35.1	41.5	0.0
Gross Profit % margin	124.2 80.1%	136.9 81.2%	161.5 78.7%	72.7 31.8%	65.6 28.8%	77.0 31.0%	89.8 33.0%	266.6 91.1%	280.0 94.6%	289.2 94.9%	295.7 94.5%	299.2 95.0%	329.7 94.8%	354.6 93.4%	391.4 93.8%	96.1 24.0%	433.7 93.0%	478.2 93.2%	495.2 92.3%	558.5 100.0%
Operating Expenses	103.9	116.7	131.5	192.1	194.6	33.8	36.4	235.0	240.2	241.2	243.9	253.2	275.7	288.1	332.1	316.7	357.3	372.5	383.9	439.0
Research & Development Expenses (R&D)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, General & Administrative Expenses (SG&A)	103.9	116.7	131.5	13.4	173.3	12.4	13.1	185.4	198.8	199.4	199.8	208.9	228.1	232.6	272.7	262.9	293.3	287.9	24.4	22.7
Operating Income % margin	20.4 13.1%	20.2 12.0%	29.9 14.6%	36.7 16.0%	33.3 14.6%	43.2 17.4%	53.5 19.6%	57.6 19.7%	55.9 18.9%	63.5 20.9%	68.9 22.0%	61.9 19.6%	72.1 20.7%	91.5 24.1%	85.1 20.4%	83.2 20.8%	108.9 23.4%	140.8 27.4%	111.3 20.7%	119.6 21.4%
Interest Income	0.0	0.0	1.8	1.7	0.0	0.2	0.2	0.3	0.1	0.2	0.2	0.7	1.3	2.8	3.9	1.7	0.1	2.1	7.2	10.0
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0
Pre-tax Income	22.6	23.6	33.6	38.5	37.0	46.7	54.8	61.7	63.9	68.0	71.1	69.1	82.5	93.3	104.2	96.9	125.8	132.2	135.9	147.4
Income Tax % effective tax rate	8.4 37.3%	9.4 39.8%	13.3 39.5%	15.3 39.8%	14.9 40.2%	19.2 41.1%	22.1 40.4%	24.5 39.7%	25.3 39.6%	27.3 40.1%	27.5 38.7%	21.6 31.3%	41.2 49.9%	21.1 22.6%	21.7 20.9%	14.4 14.8%	24.6 19.6%	29.9 22.6%	35.6 26.2%	38.4 26.0%
Net Income % margin	14.2 9.1%	14.2 8.4%	20.3 9.9%	23.2 10.1%	22.1 9.7%	27.5 11.1%	32.7 12.0%	37.2 12.7%	38.6 13.0%	40.7 13.4%	43.6 13.9%	47.5 15.1%	41.3 11.9%	72.3 19.0%	82.5 19.8%	82.6 20.6%	101.2 21.7%	102.3 19.9%	100.3 18.7%	109.0 19.5%
EPS	0.22	0.22	0.34	0.39	0.39	0.48	0.58	0.68	0.71	0.76	0.82	0.90	0.78	1.37	1.57	1.58	1.92	1.98	1.96	2.13
Diluted EPS	0.20	0.21	0.31	0.37	0.37	0.46	0.56	0.65	0.69	0.74	0.80	0.87	0.77	1.33	1.53	1.55	1.90	1.96	1.94	2.11
EBITDA % margin	26.1 16.8%	27.2 16.2%	37.5 18.3%	40.8 17.8%	37.6 16.5%	47.6 19.1%	57.9 21.2%	62.3 21.3%	60.9 20.6%	69.0 22.6%	74.4 23.8%	68.0 21.6%	78.3 22.5%	97.7 25.8%	91.9 22.0%	90.1 22.5%	115.4 24.8%	147.9 28.8%	120.2 22.4%	129.2 23.1%

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

More ideas -->

FAQ

1) What is Exponent, Inc.'s P/FCF LTM?

As of today, Microsoft Corp's last 12-month P/FCF LTM is 29.3x, based on the financial report for Jan 02, 2025 (Q1’2025). The average annual P/FCF LTM for Exponent, Inc. have been 48.2x over the past three years, and 49.9x over the past five years.

2) Is Exponent, Inc.'s P/FCF LTM Good?

As of today, Exponent, Inc.'s P/FCF LTM is 29.3x, which is higher than industry median of 23.7x. It indicates that Exponent, Inc.'s P/FCF LTM is Bad.

3) How does Exponent, Inc.'s P/FCF LTM compare to its peers?

As of today, Exponent, Inc.'s P/FCF LTM is 29.3x, which is higher than peer median of 16.3x. The list of peers includes VRSK, EFX, CRAI, TRU, BAH, FCN, HURN, ICFI, RGP, FC.

#Exponent, Inc. P/FCF LTM

#Exponent, Inc. (EXPO) P/FCF LTM comparison analysis

General

LTM P/FCF LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

#EXPO key stats

#Discover more Stock Ideas